Earnings Outlook For Synnex

Synnex (NYSE:SNX) is set to give its latest quarterly earnings report on Tuesday, 2022-09-27. Here's what investors need to know before the announcement. Analysts estimate that Synnex will report an earnings per share (EPS) of $2.74.

Synnex (NYSE:SNX) is set to give its latest quarterly earnings report on Tuesday, 2022-09-27. Here’s what investors need to know before the announcement.

Analysts estimate that Synnex will report an earnings per share (EPS) of $2.74.

Synnex bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.07, which was followed by a 2.57% drop in the share price the next day.

Here’s a look at Synnex’s past performance and the resulting price change:

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 2.65 2.73 2.67 2.07
EPS Actual 2.72 3.03 2.86 2.14
Price Change % -2.57% 1.39% 0.88% 1.75%

eps graph

Stock Performance

Shares of Synnex were trading at $85.61 as of September 23. Over the last 52-week period, shares are down 18.33%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Synnex visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Celularity Announces Net Sales And Total Revenue Expectations; Expects Net Sales Of Its Biomaterial Products And Biobanking Businesses To Be In The Range Of $11.4M-$12.1M For Q4 2023 And $22.06M-$22.76M For FY23

Celularity expects net sales of its biomaterial products and biobanking businesses to be in the range of $11.4 million to $12.1 million for the fourth quarter 2023 and $22.06 million to $22.76 million for the full year

CELU